MedTrace Logo

Study of Drug Concentration of Ondansetron and Cefazolin in Mothers and Neonates

NCT01357369 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2016-04-21

No results posted yet for this study

Summary

This study proposes to look at the pharmacokinetics of two drugs (Cefazolin and ondansetron) given routinely to pregnant women who are planning to deliver via cesarean section. The investigators will evaluate the metabolism of both drugs by the pregnant woman, the placental transfer over time, and the subsequent metabolism of the transferred drug in the neonate.

Conditions

  • Pregnancy Complications

Interventions

PROCEDURE

Phlebotomy

Blood samples will be drawn from the mother, umbilical vein and artery post delivery, and neonate with other clinical labs.

Sponsors & Collaborators

Principal Investigators

  • Brendan Carvalho · Stanford University

  • David R. Drover · Stanford University

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01357369 on ClinicalTrials.gov